BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 205 filers reported holding BRIDGEBIO PHARMA INC in Q1 2021. The put-call ratio across all filers is 1.92 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,905,365 | +16.8% | 716,927 | -23.8% | 0.34% | +24.1% |
| Q2 2023 | $16,188,227 | +3.7% | 941,176 | 0.0% | 0.27% | -4.2% |
| Q1 2023 | $15,604,698 | -64.1% | 941,176 | +32.2% | 0.29% | -50.9% |
| Q2 2021 | $43,416,000 | -1.0% | 712,197 | 0.0% | 0.58% | -10.3% |
| Q1 2021 | $43,871,000 | – | 712,197 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 3,835,722 | $82,353,000 | 42.93% |
| Kohlberg Kravis Roberts & Co. L.P. | 36,900,661 | $792,257,000 | 4.46% |
| Perceptive Advisors | 6,706,268 | $143,983,000 | 3.88% |
| Cormorant Asset Management, LP | 2,617,566 | $56,199,000 | 3.42% |
| VIKING GLOBAL INVESTORS LP | 26,620,991 | $571,553,000 | 2.98% |
| SC US (TTGP), LTD. | 2,544,738 | $54,636,000 | 2.42% |
| HHLR ADVISORS, LTD. | 4,388,690 | $94,225,000 | 1.30% |
| Fernwood Investment Management, LLC | 95,200 | $2,044,000 | 1.01% |
| AMERICAN INTERNATIONAL GROUP, INC. | 6,746,511 | $144,847,000 | 0.58% |
| Ratan Capital Management LP | 46,548 | $999,000 | 0.53% |